Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes
Recruiting · NCT05819138 · Registry updated 2026-03-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Phase 3 | 2026-03-04 | NCT05819138 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| University of Colorado, Denver | 475 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Colorado Anschutz Medical Campus | Aurora | United States | 142 |
| University of Washington Medicine Diabetes Institute (UWMDI) | Seattle | United States | 2 |